Commentary to: A new tumor vaccine: FAPτ-MT elicits effective antitumor response by
targeting Indolamine2, 3-dioxygenase in antigen presenting cells Yan-Mei Yi, Ge Zhang …

Indolamine2, 3-dioxygenase (IDO) is expressed in tumor antigen presenting cells (APCs)
and plays an important role in tumor immune tolerance. Inhibiting its activity may break …

By destroying tumor cells, conventional anticancer therapies may stimulate the host immune
system to eliminate residual disease. Anthracyclines, oxaliplatin, and ionizing irradiation …

There is an increasing number of studies utilizing dendritic cell (DC) based therapies for
cancer. With a powerful antigen-presentation capability, DCs have the potential to overcome …

Purpose Simultaneous activation of T helper 1 (Th1) cell function has crucial roles in
induction of potent cytotoxic T lymphocyte (CTL) responses in cancer immunotherapy. Here …

Dendritic cells (DCs) are immune specialized cells playing a critical role in promoting
immune response against antigens, and may represent important targets for therapeutic …

Towards superior dendritic-cell vaccines for cancer therapy | Nature Biomedical Engineering
Skip to main content Thank you for visiting nature.com. You are using a browser version with …

Dendritic cells: On the move from bench to bedside | Nature Medicine Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for …

The past decade has seen tremendous developments in novel cancer therapies through
targeting immune-checkpoint molecules. However, since increasing the presentation of …

Dendritic cells (DCs) are considered as professional antigen presenting cells (APCs),
containing a variety of subsets, that can be resident in organs or migrating among the …